114 related articles for article (PubMed ID: 37916470)
1. Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Apr; 90(4):788-799. PubMed ID: 37916470
[TBL] [Abstract][Full Text] [Related]
2. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database.
Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR
Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of post-mastectomy adjuvant chemotherapy for the treatment of patients with prognostic stage IB breast cancer: A SEER-based study.
Wang H; Peng Y; Wu J; Chen Z; Zhang H
Asian J Surg; 2023 Sep; 46(9):3634-3641. PubMed ID: 37210259
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
6. Tumor subtypes and survival in male breast cancer.
Leone J; Freedman RA; Lin NU; Tolaney SM; Vallejo CT; Leone BA; Winer EP; Leone JP
Breast Cancer Res Treat; 2021 Aug; 188(3):695-702. PubMed ID: 33770314
[TBL] [Abstract][Full Text] [Related]
7. The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis.
Li WP; Gao HF; Ji F; Zhu T; Cheng MY; Yang M; Yang CQ; Zhang LL; Li JQ; Zhang JS; Wang K
Ther Adv Med Oncol; 2020; 12():1758835920958358. PubMed ID: 33014148
[TBL] [Abstract][Full Text] [Related]
8. HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer.
Ma Y; Jiao D; Zhang J; Lv M; Chen X; Liu Z
Oncologist; 2024 Mar; 29(3):e309-e318. PubMed ID: 37769330
[TBL] [Abstract][Full Text] [Related]
9. A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Lee SB; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Son BH; Ahn SH
Breast Cancer Res Treat; 2018 Jun; 169(2):257-266. PubMed ID: 29388016
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
Chen S; Wang J; Yang L; Ji M; Chen S
J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
[TBL] [Abstract][Full Text] [Related]
11. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
12. A retrospective comparative cohort study of SEER database analysis of the prognostic value of breast-conserving surgery and mastectomy in patients with multifocal multicenter breast cancer.
Yu M; Xia L; Cao B; Wang M; Liu S; Liu S; Mou E; Li H; Wang H
Gland Surg; 2023 Feb; 12(2):165-182. PubMed ID: 36915807
[TBL] [Abstract][Full Text] [Related]
13. Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database.
Tang Z; Li L; Huang X; Zhao Y; Huang L
Breast Cancer; 2024 Mar; 31(2):205-216. PubMed ID: 38043116
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
15. Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
He Y; Gao X; Wu J; Li X; Ma Z
Clin Breast Cancer; 2022 Jul; 22(5):410-417. PubMed ID: 35473920
[TBL] [Abstract][Full Text] [Related]
16. The disparities in prognostic prediction and annualized hazard function in different molecular subtypes between young Chinese and White American women with breast cancer.
Zeng Y; Wang J; Zhong X; Xiang Z; Yang T; Yu S; Dai Z; Xu N; Liu L
Front Oncol; 2023; 13():1199492. PubMed ID: 37492473
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients.
Zhang J; Yang C; Lei C; Zhang Y; Ji F; Gao H; Yang M; Zhang L; Li J; Zhu T; Li W; Zhuang X; Wang K
Breast; 2021 Aug; 58():10-17. PubMed ID: 33878598
[TBL] [Abstract][Full Text] [Related]
18. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
19. The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.
Hou L; Qiu M; Chen M; Li F; Li J; Deng S; Yang Y; Du Z; Yang H
Gland Surg; 2021 Jun; 10(6):1889-1898. PubMed ID: 34268073
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of the Oncotype DX Recurrence Score in T
Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]